SARS-CoV-2-specific T cell responses in patients with COVID-19 and unexposed individuals

15Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), an ongoing pandemic disease. In the current review, we describe SARS-CoV-2-specific CD4+ and CD8+ T-cell responses in acute and convalescent COVID-19 patients. We also discuss the relationships between COVID-19 severity and SARS-CoV-2-specific T-cell responses and summarize recent reports regarding SARS-CoV-2-reactive T cells in SARS-CoV-2-unexposed individuals. These T cells may be cross-reactive cells primed by previous infection with human common-cold coronaviruses. Finally, we outline SARS-CoV-2-specific T-cell responses in the context of vaccination. A better understanding of SARS-CoV-2-specific T-cell responses is needed to develop effective vaccines and therapeutics.

Author supplied keywords

Cite

CITATION STYLE

APA

Rha, M. S., Reum Kim, A., & Shin, E. C. (2021, February 1). SARS-CoV-2-specific T cell responses in patients with COVID-19 and unexposed individuals. Immune Network. Korean Association of Immunologists. https://doi.org/10.4110/in.2021.21.e2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free